Axon Enterprise is scheduled to report first-quarter 2026 results on May 6 after the market close, and investors will be looking for whether axon stock can keep up its recent run of earnings beats. Wall Street expects revenue of $780.6 million and profit of $1.66 per share, with both estimates pointing to continued growth from a year earlier.
The revenue forecast would mark a 29.3% increase from the same quarter last year, while the earnings estimate is up 17.7%. That follows a pattern Axon has built over the past year: it topped the Zacks Consensus Estimate in three of the last four quarters and missed once, with an average surprise of 12.3% across that stretch. In the most recent report, the company earned $2.15 per share, beating estimates by 28.7%.
The latest consensus has not moved in 60 days, and the most accurate estimate is also $1.66 per share. That gives Axon an Earnings ESP of 0.00%, which leaves the quarter leaning more on execution than on a late shift in analyst expectations. Traders watching the stock will also be parsing two business lines that help frame the report: the Connected Devices segment is expected to post $423 million in revenue, while Software & Services is expected to generate $354 million in net sales.
February brought a separate test of Axon’s strategy when it acquired Carbyne, a provider of cloud contact center technology solutions to public safety agencies. The deal folded Carbyne’s cloud-native 911 technology into the company’s ecosystem under Axon 911, widening the company’s push beyond body cameras and TASER hardware into communications software tied to emergency response.
That expansion, however, comes with a cost. Higher integration expenses, rising wages and stock-based compensation are expected to have weighed on the bottom line in the quarter, even as the company benefits from demand tied to TASER 10 products, cartridge sales, Axon Body 4, virtual reality training services, Dedrone offerings and AI-powered command-and-control software. The question for Wednesday’s report is less whether Axon can grow and more whether it can keep that growth clean enough to satisfy a market that has rewarded the company for beating expectations but still wants proof the newer businesses can scale without squeezing margins.
For now, axon stock heads into the print with a familiar setup: strong sales expectations, a history of outperformance and a fresh acquisition that could broaden the company’s reach, but also a cost structure that may make the next beat more difficult than the last.
